|
MCE 国际站:Codrituzumab
CAS:1365267-33-9
品牌:MedChemExpress (MCE)
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性:Codrituzumab 是一种靶向GPC3 (glypican-3) 的单克隆抗体。 GPC3 是一种在肝细胞癌 (HCC) 细胞表面表达的癌胚蛋白。 Codrituzumab 诱导抗体依赖性细胞毒性 (ADCC) 并抑制肿瘤生长[1][2]。
热销产品:Elafibranor | Cyclopamine | Berberine (chloride) | Abciximab | INCB3344 | [Leu15]-Gastrin I (human) | CNX-500 | Pemetrexed | N-Acetylcysteine amide | Evolocumab
研究领域:Others
作用靶点:Others
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献:[1]. Mika Endo, et al. Abstract 2747: Anti-glypican-3 monoclonal antibody (codrituzumab/GC33/RO5137382) treatment enhances tumor infiltration of PD-L1-positive macrophages, and combination therapy with anti-PD-L1 monoclonal antibody promotes antitumor effects. Cancer Res (2018) 78 (13_Supplement): 2747.
[2]. Chen G, et al. Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab. Oncotarget. 2018 Jan 2;9(12):10436-10444.
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-8-22 07:19
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社